Alkermes to Participate in Upcoming Investor Conferences

Leerink Partners Global Healthcare Conference 2025Date/Time: Wednesday, March 12, 2025 at 11:20 a.m. ET (3:20 p.m. GMT) Leerink Partners Global Healthcare Conference 2025 Date/Time:  Wednesday, March 12, 2025 at11:20 a.m. ET( 3:20 p.m. GMT ) The live webcasts may be accessed under the Investors tab onwww.alkermes.comand will be archived for 14 days. About Alkermes plc Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field...

DUBLIN, 26/02/2025 (informazione.news - comunicati stampa - salute e benessere)

 Wednesday, March 12, 2025 at 11:20 a.m. ET ( 3:20 p.m. GMT )

The live webcasts may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders, including narcolepsy and idiopathic hypersomnia. Headquartered in Ireland , Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio . For more information, please visit Alkermes' website at www.alkermes.com.

Alkermes Contact:
Jamie Constantine
Investor Relations
+1 781 873 2402

Logo - https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/alkermes-to-participate-in-upcoming-investor-conferences-302386278.html